Abstract CT160: The integration of PD1 blockade with epigenetic therapy is highly active and safe in heavily treated patients with T-cell lymphomaEnrica Marchi, Owen A. O’Connor, Jennifer Kimberly Lue et al.|Cancer Research|2020Cited by 4
Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary EraLeora Boussi, Salvia Jain, Min Jung Koh et al.|Blood|2022Cited by 1